Drotaverine

Chemical formula: C₂₄H₃₁NO₄  Molecular mass: 397.507 g/mol  PubChem compound: 1712095

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A03AD02 Drotaverine A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AD Papaverine and derivatives
Discover more medicines within A03AD02

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 14009-24-6
DrugBank Drug: DB06751
PubChem Compound: 1712095
RxNorm Ingredient: 23684
SNOMED-CT Concept: 719933003
Drotaverine (substance)
UNII Identifier: 98QS4N58TW
DROTAVERINE

Medicines

Drotaverine is an active ingredient of these brands:

Cyprus (CY)

  • NO-SPA as DROTAVERINE HYDROCHLORIDE

Estonia (EE)

  • NO-SPA as DROTAVERINE HYDROCHLORIDE

Lithuania (LT)

  • DOSPAX as DROTAVERINE HYDROCHLORIDE
  • NO-SPA as DROTAVERINE HYDROCHLORIDE

Malta (MT)

  • NO-SPA as DROTAVERINE HYDROCHLORIDE
  • SPAVERIN as DROTAVERINE HYDROCHLORIDE

Mexico (MX)

  • NO-SPA as DROTAVERINE HYDROCHLORIDE

Nigeria (NG)

  • SPASFIX as DROTAVERINE HYDROCHLORIDE

Poland (PL)

Romania (RO)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈